Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor-alpha.
Hiroki
H
Mitoma
Takahiko
T
Horiuchi
Hiroshi
H
Tsukamoto
D000911:Antibodies, Monoclonal / Q000378:metabolism*; D003424:Crohn Disease / Q000378:metabolism*; D000068800:Etanercept; D005765:Gastrointestinal Agents / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept